AutoDock-SS: AutoDock for Multiconformational Ligand-Based Virtual Screening

• Published in: Journal of chemical information and modeling Vol. 64; no. 9; pp. 3779 - 3789
• Main Authors: Ni, Boyang, Wang, Haoying, Khalaf, Huda Kadhim Salem, Blay, Vincent, Houston, Douglas R.
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 13.05.2024
• Subjects: Chemical Information; Datasets; Decoys; Drug Evaluation, Preclinical - methods; Ligands; Molecular Conformation; Molecular Docking Simulation; Protein Conformation; Proteins; Proteins - chemistry; Proteins - metabolism; Screening; User-Computer Interface; Workflow
• ISSN: 1549-9596; 1549-960X
• DOI: 10.1021/acs.jcim.4c00136

Ligand-based virtual screening (LBVS) can be pivotal for identifying potential drug leads, especially when the target protein’s structure is unknown. However, current LBVS methods are limited in their ability to consider the ligand conformational flexibility. This study presents AutoDock-SS (Similarity Searching), which adapts protein–ligand docking for use in LBVS. AutoDock-SS integrates novel ligand-based grid maps and AutoDock-GPU into a novel three-dimensional LBVS workflow. Unlike other approaches based on pregenerated conformer libraries, AutoDock-SS’s built-in conformational search optimizes conformations dynamically based on the reference ligand, thus providing a more accurate representation of relevant ligand conformations. AutoDock-SS supports two modes: single and multiple ligand queries, allowing for the seamless consideration of multiple reference ligands. When tested on the Directory of Useful DecoysEnhanced (DUD-E) data set, AutoDock-SS surpassed alternative 3D LBVS methods, achieving a mean AUROC of 0.775 and an EF1% of 25.72 in single-reference mode. The multireference mode, evaluated on the augmented DUD-E+ data set, demonstrated superior accuracy with a mean AUROC of 0.843 and an EF1% of 34.59. This enhanced performance underscores AutoDock-SS’s ability to treat compounds as conformationally flexible while considering the ligand’s shape, pharmacophore, and electrostatic potential, expanding the potential of LBVS methods.